SPH Notice – Kevin James Hickman and Joanna Hickman
DISCLOSURE OF MOVEMENT OF 1% OR MORE IN SUBSTANTIAL HOLDING OR CHANGE IN
NATURE OF RELEVANT INTEREST, OR BOTH
SECTIONS 277 AND 278, FINANCIAL MARKETS CONDUCT ACT 2013
To: NZX Limited (NZX)
And: Ryman Healthcare Limited
Relevant event being disclosed: Change in the nature of the relevant interest
Date of relevant event: 1 December 2019
Date this disclosure made: 2 December 2019
Date last disclosure made: 24 June 2013
Substantial product holder(s) giving disclosure
Kevin James Hickman and Joanna Hickman
Summary of substantial holding
Class of quoted voting products: Fully paid ordinary shares in Ryman Healthcare Limited (NZX: RYM)
(the “Shares”)
Summary for:
Kevin James Hickman and Joanna Hickman
For this disclosure:
(a) total number held in class: 35,000,000
(b) total in class: 500,000,000
(c) total percentage held in class: 7.0%
For last disclosure:
(a) total number held in class: 35,834,955
(b) total in class: 500,000,000
(c) total percentage held in class: 7.17%
Details of transactions and events giving rise to relevant interest
Details of the transactions or other events requiring disclosure:
On 6
November 2019 John Anthony Callaghan died aged 76 at Christchurch Hospital, with Kevin
James Hickman and Joanna Hickman remaining as the trustees of The Hickman Family Trust.
On 1 December 2019 Kevin James Hickman and Joanna Hickman retired as trustees of The Hickman
Family Trust and Hickman Family Trustees Limited was appointed as the trustee of The Hickman
Family Trust. No consideration was applicable for this change of registered holder.
Kevin James Hickman and Joanna Hickman jointly hold 100% of the shares in Hickman Family
Trustees Limited. The directors of Hickman Family Trustees Limited are Kevin James Hickman,
Joanna Hickman and Warren James Bell.
Details after relevant event
Details for Kevin James Hickman and Joanna Hickman
Nature of relevant interest: Kevin James Hickman and Joanna Hickman jointly hold 100% of the
shares in Hickman Family Trustees Limited and are directors of Hickman Family Trustees Limited.
Kevin Hickman and Joanna Hickman are also beneficiaries of The Hickman Family Trust.
For that relevant interest:
(a) number held in class: 35,000,000
(b) percentage held in class: 7.0%
(c) current registered holders: Kevin James Hickman and Joanna Hickman
(d) registered holder once transfer is registered: Hickman Family Trustees Limited
Additional information
Address for substantial product holders:
Hickman Family Trustees Limited, 92C Russley Road, Christchurch 8042.
Contact details for enquiries: Brent Schumacher, (03) 336 0260, brent.schumacher@hft.net.nz.
Nature of connection between substantial product holders: Kevin James Hickman and Joanna
Hickman have a similar or related substantial holding in Ryman Healthcare Limited, are disclosing the
same change of nature of relevant interest in this notice, and are spouses.
Name of any other person believed to have given, or believed to be required to give, a disclosure
under the Financial Markets Conduct Act 2013 in relation to the financial products to which this
disclosure relates: Hickman Family Trustees Limited
Other information: The change in shareholding between disclosures as set out in the Summary of
Substantial Shareholding section above was disclosed by Mr Kevin Hickman in the D&O ongoing
disclosure notice published on 25 May 2018 but did not require a SPH notice to be filed.
Directors’ and senior managers’ disclosure
Warren James Bell is also a director of Ryman Healthcare Limited. A separate disclosure has been,
or will be, made by Warren Bell in relation to this transaction.
Certification
I, Brent Jeffrey Schumacher, certify that, to the best of my knowledge and belief, the information
contained in this disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- RAK — Rakon Limited: Substantial Product Holder Disclosures2019-10-03
“1 Disclosure of movement of 1% or more in substantial holding or change in nature of relevant interest, or both Sections 277 and 278, Financial Markets Conduct Act 2013 To NZX and To Rakon Limited Relevant event being disclosed: Change in the nature of relevant inter…”
- CHI — Channel Infrastructure NZ Limited: SPH Notice – Wellington Management Group LLP2019-11-06
“100080615/3821103.1 Disclosure of movement of 1% or more in substantial holding or change in nature of relevant interest, or both Sections 277 and 278, Financial Markets Conduct Act 2013 Note: This form must be completed in accordance with the instructions at the end of the…”
- AGL — Accordant Group Limited: SPH Notice – Masfen Securities Limited2019-09-12
“1 Disclosure of movement of 1% or more in substantial holding or change in nature of relevant interest, or both Sections 277 and 278, Financial Markets Conduct Act 2013 To NZX and To AWF Madison Group Limited Relevant event being disclosed: Movement of 1% or more in subs…”